BERLIN, Jan 27 (Reuters) - Roche's experimental obesity drug, which works in a similar way to Eli Lilly's Zepbound, produced ...

A new voluntary Medicare model starts in July, and it could save you $11,000 per year. But there are steps you need to take ...

New weight-loss drugs in the works will offer more choices beyond GLP-1 options Wegovy and Zepbound. What to know about ...

With GLP-1 drugs rising in popularity, how are businesses adapting to a new type of consumer?

Mid-stage trial data showed Roche's experimental shot delivered weight loss on par with leading obesity treatments, ...

Genetic weight loss is reframing obesity medicine by explaining why diets and drugs fail—and how personalized treatment ...

Analysts say GLP-1 weight-loss drugs could make airfare cheaper by reducing fuel costs as passengers get thinner. Experts ...

Are GLP-1 drugs prescribed for weight loss becoming too outsized a line item for continued coverage through the state ...

'It only makes sense that the weight of passengers impacts costs,' an equity analyst for a financial firm said ...

As obesity rates among Americans drop and weight loss drugs lead to a slimmer society, airlines could save on fuel costs, ...

Many people who use these medications don’t want to stay on them long term. But research has repeatedly shown that quitting ...

Bunnie XO shares her harrowing experience with an experimental weight-loss drug, describing severe depression and suicidal ...